Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy
Clinical trial NCT06236061 · COMPLETED
Trial details
- NCT number
- NCT06236061
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-08
- Primary completion
- 2025-05-28
- Enrollment
- 718
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.